SS

Sharad Sundaramony

Director Director DIN 05177028
DIN 05177028 First appointment Jan 2012 Primary industry Real Estate and Construction
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Sharad Sundaramony

Data last updated:

Sharad Sundaramony was a Director at Apranje Estates Limited (2016–2017) and Designated Partner at Martin William Biotech Llp (from 2012). The companies operate in Real Estate and Construction.

DIN 05177028
Primary Designation Director
Industry Real Estate and Construction
First Appointment 24 Jan 2012
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apranje Estates Limited U45200KA2008PLC046250
Director27 Sep 20162008₹1.73 Cr (FY 2024)Active
Designated Partner24 Jan 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Martin William Biotech Llp
Apranje Estates Limited
Premium access

Shareholding and investment profile for Sharad Sundaramony

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharad Sundaramony

Sharad Sundaramony was first appointed on 24 Jan 2012 as Designated Partner at Martin William Biotech Llp. The most recent appointment on record is 27 Sep 2016 at Apranje Estates Limited.

Sharad Sundaramony held 2 earlier board appointments: Apranje Estates Limited (Director, 27 Sep 2016 to 01 Aug 2017); Martin William Biotech Llp (Designated Partner, from 24 Jan 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available